Patents by Inventor Paul BEAVIS

Paul BEAVIS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODIFIED T CELLS AND USES THEREOF
    Publication number: 20250101073
    Abstract: The present invention generally relates to T cells that are modified to enhance the efficiency of adoptive cellular therapy by modulating dendritic cell activity, a composition comprising modified T cells, vectors and methods for the treatment of cancer comprising administering modified T cells. In particular, the present invention provides modified T cells for use in adoptive cellular therapies for the treatment of solid tumours.
    Type: Application
    Filed: December 11, 2024
    Publication date: March 27, 2025
    Inventors: Paul Beavis, Philip Darcy
  • Modified T cells and uses thereof
    Patent number: 12202855
    Abstract: The present invention generally relates to T cells that are modified to enhance the efficiency of adoptive cellular therapy by modulating dendritic cell activity, a composition comprising modified T cells, vectors and methods for the treatment of cancer comprising administering modified T cells. In particular, the present invention provides modified T cells for use in adoptive cellular therapies for the treatment of solid tumours.
    Type: Grant
    Filed: June 25, 2019
    Date of Patent: January 21, 2025
    Assignee: Peter MacCallum Cancer Institute
    Inventors: Paul Beavis, Philip Darcy
  • MODIFIED T CELLS AND USES THEREOF
    Publication number: 20210379107
    Abstract: The present invention generally relates to T cells that are modified to enhance the efficiency of adoptive cellular therapy by modulating dendritic cell activity, a composition comprising modified T cells, vectors and methods for the treatment of cancer comprising administering modified T cells. In particular, the present invention provides modified T cells for use in adoptive cellular therapies for the treatment of solid tumours.
    Type: Application
    Filed: June 25, 2019
    Publication date: December 9, 2021
    Inventors: Paul BEAVIS, Philip DARCY